Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temocillin for complicated urinary tract infections due to ESBL-producing or AmpC-hyperproducing Enterobacteriaceae in the United Kingdom
2008-005912-41Phase 4Terminated
- Sponsor
- Belpharma
- Start
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of temocillin in complicated urinary tract infection (cUTI) and urinary tract infection (UTI), sponsored by Belpharma. Primary endpoint: Eradication rate at end of therapy. Started Oct 2008; status: terminated.
02
Drugs
temocillin
03
Conditions
complicated urinary tract infection (cUTI)urinary tract infection (UTI)
Beyond the preview
Go deeper on 2008-005912-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005912-41.